Description

CJC‑1295 DAC – Long‑Acting Growth Hormone Releasing Peptide

Overview
CJC‑1295 DAC is a synthetic peptide designed to stimulate the body’s natural release of growth hormone. The “DAC” (Drug Affinity Complex) modification extends its half‑life, allowing it to remain active in the system for an extended period. This results in sustained growth hormone secretion with less frequent dosing compared to non‑DAC peptides.

Benefits

• Supports increased natural growth hormone release
• May promote lean muscle growth and muscle preservation
• Can aid in improved recovery from training and injury
• Supports fat metabolism and body composition improvements
• May enhance overall energy and vitality

Mechanism of Action
CJC‑1295 DAC works by binding to growth hormone‑releasing hormone (GHRH) receptors, signaling the pituitary gland to release growth hormone. The DAC modification slows its breakdown, prolonging circulation and enhancing sustained growth hormone release.

Dosing (Research Use Only)

• Typical dose: 1–2 mg once per week
• Frequency: Once weekly due to extended action
• Administration: Subcutaneous injection
• Cycle length: Often 8–12 weeks or longer depending on goals
• Injection sites: Abdomen, thigh, or upper arm, rotating sites each injection
  Because of the long half‑life, weekly dosing is generally sufficient to maintain elevated growth hormone pulses.

Expected Results

• Increases in growth hormone levels typically begin after the first few injections
• Noticeable improvements in recovery, muscle fullness, and energy may appear over several weeks
• Supports fat loss and lean mass improvements over the course of a cycle

Side Effects

• Injection site reactions such as redness or mild irritation
• Mild water retention in some individuals
• Temporary tiredness or headache
• Possible increased hunger
• Rare: tingling or numbness in hands or feet
  Most side effects are mild and tend to occur early in use or with higher doses.

Warnings

• Experimental peptide not approved for general medical use
• Not recommended during pregnancy or breastfeeding
• People with medical conditions, especially endocrine or metabolic disorders, should consult a healthcare professional before use
• Sustained elevated growth hormone can influence glucose metabolism and hydration status

Summary
CJC‑1295 DAC is a long‑acting peptide that promotes sustained release of growth hormone. It is typically administered once weekly and may support improved recovery, lean muscle, fat metabolism, and overall vitality. While generally well tolerated in research settings, it remains experimental with limited long‑term human safety data